Study of the anti-tumor effects by oligonucleotides among the patients with primary lung cancer
Not Applicable
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000017816
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Having any treatment for active local or systemic infectious disease 2. Any multiple cancer 3. Needs treatment with systemic corticosteroids or immunosuppressive agents 4. Problematic mental disorder 5. Investigator considers to be inappropriate to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T cell proliferation assay
- Secondary Outcome Measures
Name Time Method Inflammatory cytokines